Evidence map›Paper›PMID 33968698›Full record

ArticleGland surgery2021

Effect of postoperative chemotherapy on blood glucose and lipid metabolism in patients with invasive breast cancer.

Aiying Qi, Yanping Li, Susu Yan, Huiying Sun, Meiling Zhao, Yuhui Chen

Open access · diamondAbstract read
In one paragraph

Article in Gland surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 35 citations in OpenAlex.

  1. Dyslipidaemias in cancer patients.European heart journal · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aiying QiDepartment of General Surgery, the First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Yanping LiDepartment of General Surgery, the First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Susu YanDepartment of General Surgery, the First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Huiying SunDepartment of General Surgery, the First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Meiling ZhaoDepartment of General Surgery, the First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Yuhui ChenDepartment of General Surgery, the First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Chinese People's Liberation Army · CNChinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChemotherapy can lead to abnormal metabolism and affect the quality of life of patients after operation. Here we explore the effect of postoperative chemotherapy on blood glucose and lipid metabolism in patients with invasive breast cancer and thus provide evidence for the prevention and treatment of blood glucose and lipid disorders after surgery.

methodsFrom January 2019 to December 2020, data from 141 patients with invasive breast cancer in our hospital were retrospectively collected. The levels of fasting blood glucose and blood lipid profiles [including total cholesterol, triglyceride, high-density lipoprotein (HDL), and low-density lipoprotein (LDL)] were compared before and after chemotherapy. Meanwhile, the metabolic risk factors for abnormal blood glucose and lipid profiles were analyzed.

resultsFasting blood glucose levels significantly increased after treatment (5.21±0.89

conclusionsPostoperative chemotherapy can lead to the elevated triglyceride and fasting blood glucose and decreased HDL in patients with breast cancer. Anthracycline-based chemotherapy is a protective factor for the increase of fasting blood glucose, and more than 6 cycles of chemotherapy is a risk factor for the increase of fasting blood glucose.

Indexed as

blood glucoseblood lipidsinvasive breast cancerPostoperative chemotherapy

Identifiers

PMID33968698
PMCPMC8102220
OpenAlexW3154014375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.